Noaber Ventures

Noaber Ventures B.V. is the venture capital division of Noaber Foundation, established in 2000 and located in Ede, the Netherlands. The firm focuses on investing in initiatives that drive social transformation, particularly within the healthcare sector. Its investment strategy encompasses both direct investments and fund-of-fund approaches, targeting early and later-stage companies primarily in Northern and Eastern Europe. Noaber Ventures emphasizes sectors such as e-health, information technology, and healthcare technology, aiming to foster innovation and improve healthcare delivery through advanced solutions.

Mineke Baan-Pas

Co-Founder and Board Member

Matthijs Blokhuis

Director

Roel Dekkers

Investment Manager

17 past transactions

Alba Health

Pre Seed Round in 2023
Alba Health specializes in digital gut health support for children, utilizing artificial intelligence and gut microbiome testing. The company offers a microbiome testing service that provides comprehensive insights into a child's gut health through an easy-to-use stool test kit. This kit is analyzed in a certified laboratory, and the detailed results are returned to parents, who can then collaborate with dieticians to develop personalized action plans to enhance their child's health. Additionally, Alba Health anonymizes the test results, potentially contributing to broader discoveries that could improve children's overall health and well-being.

Newsenselab (M-sense)

Seed Round in 2021
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Elsa

Seed Round in 2021
Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

Sweetch

Series A in 2021
Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions aimed at improving clinical outcomes for individuals with chronic conditions. The company's hyper-personalized engagement platform offers tailored recommendations that consider the appropriate timing, tone, and real-world context for each patient's health journey. This approach enables pharmaceutical companies, medical device manufacturers, payers, and healthcare providers to foster continuous relationships and effectively engage with patients at scale, ultimately supporting individuals in achieving their health goals.

Elsa

Seed Round in 2020
Elsa Science AB, founded in 2017 and based in Stockholm, Sweden, operates a digital health platform focused on rheumatoid arthritis. The company empowers patients to take an active role in their healthcare by providing tools that facilitate personal research into their condition. Through its application, users can monitor symptoms, diet, and lifestyle factors, gaining insights into how these elements influence their disease activity. Elsa collaborates with the Riskminder foundation and scientific studies at Karolinska Institutet to deliver reliable data and research findings. By enabling patients to track their responses to medications and overall health status, Elsa supports healthcare professionals in managing chronic diseases more effectively, improving treatment personalization and proactive care.

Newsenselab (M-sense)

Seed Round in 2019
M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

NewCompliance

Series A in 2019
NewCompliance is a healthcare technology company focused on enhancing the quality and safety of patient care through its innovative platform. The company collaborates with industry partners such as Stryker, Medtronic, Skytron, and Philips to deliver interoperable IT solutions. Its flagship product, the ACTIQ platform, offers predictive dashboarding and analytics, allowing medical personnel to access real-time feedback and management information. This technology is designed to support caregivers in departments such as surgery, emergency care, and intensive care, ultimately aiming to reduce costs, improve hospital safety, and enhance patient satisfaction throughout the surgical patient journey. By prioritizing efficiency and effectiveness, NewCompliance positions itself as a leader in the healthcare technology sector.

LeQuest

Venture Round in 2019
LeQuest B.V., founded in 2011 and based in Rotterdam, the Netherlands, specializes in e-training services for the healthcare industry. The company has developed a software platform that enables healthcare professionals to receive training on the use of complex medical equipment. This platform includes several modules that digitally reproduce medical devices and their functionalities. As the healthcare sector increasingly relies on advanced medical technology, LeQuest's software assists healthcare institutions in managing staff competencies and knowledge. The platform ensures that certification, registration, and retraining for specific medical equipment are systematically addressed, enhancing the overall proficiency of healthcare professionals.

Ambient Clinical Analytics

Series B in 2018
Ambient Clinical Analytics, Inc. develops healthcare data assimilation and decision support tools aimed at enhancing patient care in intensive care units, operating rooms, and emergency departments. The company's flagship product, AWARE, integrates with various electronic health record systems and bedside monitors to deliver crucial patient information on a single-screen dashboard, facilitating real-time clinical decision-making. Additionally, Ambient offers the Mayo Clinic YES Board, which enhances patient flow by providing real-time situational awareness. The company also specializes in syndromic surveillance solutions, including Sepsis DART, which aids in the detection and confirmation of sepsis, and the Ventilator-Induced Lung Injury Sniffer, designed for ventilator monitoring. Furthermore, Ambient provides the Synthesis Platform, which serves as an integration tool for AWARE and the Mayo Clinic solutions. Founded in 2013 and headquartered in Rochester, Minnesota, Ambient Clinical Analytics focuses on reducing healthcare costs and improving patient outcomes through its innovative tools and technology.

LeQuest

Venture Round in 2017
LeQuest B.V., founded in 2011 and based in Rotterdam, the Netherlands, specializes in e-training services for the healthcare industry. The company has developed a software platform that enables healthcare professionals to receive training on the use of complex medical equipment. This platform includes several modules that digitally reproduce medical devices and their functionalities. As the healthcare sector increasingly relies on advanced medical technology, LeQuest's software assists healthcare institutions in managing staff competencies and knowledge. The platform ensures that certification, registration, and retraining for specific medical equipment are systematically addressed, enhancing the overall proficiency of healthcare professionals.

Noona Healthcare

Seed Round in 2016
Noona Healthcare Oy is a Finnish company that specializes in a web-based mobile platform designed for monitoring the wellbeing of breast cancer patients. Founded in 2014 and based in Helsinki, Noona allows patients to report symptoms related to their treatment directly to their healthcare providers through mobile devices, tablets, and computers. This real-time communication enhances the patient-clinic relationship, enabling clinical staff to promptly address severe symptoms and improve overall care quality. The platform also supports researchers in developing new cancer therapies by integrating digital data with patient diagnosis, treatment, and genetic information. As a result, Noona Healthcare contributes to better patient outcomes and optimizes resource allocation in oncology care. The company operates as a subsidiary of Varian Medical Systems, Inc.

Institute for Positive Health

Seed Round in 2016
Institute for Positive Health (iPH) is the driving force behind the Positive Health movement. The foundation was founded by Machteld Huber, the founder of the philosophy. The institute wants to stimulate, strengthen and accelerate the movement that has arisen around Positive Health. For example, together we make the Netherlands the largest Blue Zone in the world, a place where people live longer, healthier and happier than anywhere else in the world.

EarlySense

Series F in 2015
EarlySense Ltd. specializes in developing advanced patient monitoring systems for healthcare facilities, including hospitals and rehabilitation centers. The company offers a range of products, such as the EarlySense System, which provides continuous monitoring of heart rate, respiratory rate, and patient motion, enabling healthcare teams to detect early signs of patient deterioration and prevent falls and pressure ulcers. Additionally, the Central Display Station allows nurses to supervise multiple patients effectively, while the contact-free consumer health monitor, known as LIVE, provides valuable health information to users and their caregivers. EarlySense's technology is employed in various medical settings, including surgical wards, oncology, and long-term care facilities. Founded in 2004 and headquartered in Ramat Gan, Israel, with a marketing office in Woburn, Massachusetts, the company has formed partnerships to enhance its product offerings and expand its market reach.

Fundis

Seed Round in 2014
The welfare state makes way for a society with its own responsibility and active participation in social life. The focus is on quality of life rather than on limitations or illness. The share of collectively funded healthcare is getting smaller. Own direction and freedom of choice are paramount. Care and support are more often organized in their own environment: with family, neighbors, a (social) network or a purchasing collective. Innovation and quality improvement As a network organization, Fundis responds flexibly to the ever-changing (care) demand. Fundis is continuously expanding, keeping up-to-date or improving the care and service offering and business operations. Fundis does not do this alone. With existing companies within the Fundis group, by adding new companies to the group or by working intensively with partners outside the group. Everything with the aim of providing high-quality care and services for health and well-being to frail elderly and chronically ill people.

EarlySense

Series C in 2010
EarlySense Ltd. specializes in developing advanced patient monitoring systems for healthcare facilities, including hospitals and rehabilitation centers. The company offers a range of products, such as the EarlySense System, which provides continuous monitoring of heart rate, respiratory rate, and patient motion, enabling healthcare teams to detect early signs of patient deterioration and prevent falls and pressure ulcers. Additionally, the Central Display Station allows nurses to supervise multiple patients effectively, while the contact-free consumer health monitor, known as LIVE, provides valuable health information to users and their caregivers. EarlySense's technology is employed in various medical settings, including surgical wards, oncology, and long-term care facilities. Founded in 2004 and headquartered in Ramat Gan, Israel, with a marketing office in Woburn, Massachusetts, the company has formed partnerships to enhance its product offerings and expand its market reach.

& NIPED

Venture Round in 2008
& NIPED is an E-health platform based in Amsterdam, Netherlands, founded in 2005. The company offers a patented knowledge platform designed to facilitate personal health management within healthcare systems. This platform enables users to create and monitor a personalized health profile through a secure online account, incorporating biometrics and laboratory research for a comprehensive view of their health. Based on this profile, users receive tailored referrals for medical, psychological, and lifestyle interventions. The platform includes a complete range of stepped-care intervention options, ensuring that users find the best match for their health needs. & NIPED has developed various prevention applications, such as Preventiekompas and Persoonlijke Gezondheidscheck, which provide self-health monitoring services through online questionnaires that assess lifestyle, mental, physical, and familial factors, ultimately empowering users to maintain a healthy lifestyle.

Alba Health

Alba Health specializes in digital gut health support for children, utilizing artificial intelligence and gut microbiome testing. The company offers a microbiome testing service that provides comprehensive insights into a child's gut health through an easy-to-use stool test kit. This kit is analyzed in a certified laboratory, and the detailed results are returned to parents, who can then collaborate with dieticians to develop personalized action plans to enhance their child's health. Additionally, Alba Health anonymizes the test results, potentially contributing to broader discoveries that could improve children's overall health and well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.